Galle Liz has filed 3 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 778 shares of CVRx, Inc. ($CVRX) on October 16, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 16, 2023 | CVRx, Inc. | $CVRX | Galle Liz | VP OF GLOBAL CLINICAL RESEARCH | M | Common Stock | 778 | $0.24 | 778.0000 | 20,801,350 | 9999.99% | 0.00% |
| Oct. 16, 2023 | CVRx, Inc. | $CVRX | Galle Liz | VP OF GLOBAL CLINICAL RESEARCH | M | Stock Option (right to buy) | 778 | $0.00 | 0.0000 | 20,801,350 | 100.00% | 0.00% |
| Jan. 18, 2023 | CVRx, Inc. | $CVRX | Galle Liz | VP OF GLOBAL CLINICAL RESEARCH | A | Stock Option (right to buy) | 26000 | $0.00 | 26,000.0000 | 20,532,838 | 9999.99% | 0.13% |